Publications indexed to the term Macular Degeneration
| Faculty | Title |
|---|---|
| 1 | Identification of Novel Retinal Pericyte-Targeting rAAV Vectors Through Directed Evolution. (Patel DD, Marsic D, Periasamy R, Zolotukhin S, Lipinski DM) Transl Vis Sci Technol 2022 Aug 01;11(8):28 3 Citations |
| 1 | Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28. (Chew EY, Clemons TE, Agrón E, Domalpally A, Keenan TDL, Vitale S, Weber C, Smith DC, Christen W, AREDS2 Research Group) JAMA Ophthalmol 2022 Jul 01;140(7):692-698 91 Citations |
| 1 | Artificial intelligence-based strategies to identify patient populations and advance analysis in age-related macular degeneration clinical trials. (Yaghy A, Lee AY, Keane PA, Keenan TDL, Mendonca LSM, Lee CS, Cairns AM, Carroll J, Chen H, Clark J, Cukras CA, de Sisternes L, Domalpally A, Durbin MK, Goetz KE, Grassmann F, Haines JL, Honda N, Hu ZJ, Mody C, Orozco LD, Owsley C, Poor S, Reisman C, Ribeiro R, Sadda SR, Sivaprasad S, Staurenghi G, Ting DS, Tumminia SJ, Zalunardo L, Waheed NK) Exp Eye Res 2022 Jul;220:109092 6 Citations |
| 2 | Calcium and hydroxyapatite binding site of human vitronectin provides insights to abnormal deposit formation. (Shin K, Kent JE, Singh C, Fujimoto LM, Yu J, Tian Y, Im W, Marassi FM) Proc Natl Acad Sci U S A 2020 Aug 04;117(31):18504-18510 14 Citations |
| 1 | PARACENTRAL ACUTE MIDDLE MACULOPATHY AS A PRESENTING SIGN OF CENTRAL RETINAL ARTERY OCCLUSION IN SICKLE CELL DISEASE TREATED WITH TISSUE PLASMINOGEN ACTIVATOR. (Chua MR, Giovinazzo JV, Kaplan RI, Connor T, Kellner C, Barash A, Rosen RB) Retin Cases Brief Rep 2022 Sep 01;16(5):553-557 2 Citations |
| 1 | Why is Zeaxanthin the Most Concentrated Xanthophyll in the Central Fovea? (Widomska J, SanGiovanni JP, Subczynski WK) Nutrients 2020 May 07;12(5) 29 Citations |
| 1 | NOD-like Receptors in the Eye: Uncovering Its Role in Diabetic Retinopathy. (Lim RR, Wieser ME, Ganga RR, Barathi VA, Lakshminarayanan R, Mohan RR, Hainsworth DP, Chaurasia SS) Int J Mol Sci 2020 Jan 30;21(3) 46 Citations |
| 2 | Regeneration of the zebrafish retinal pigment epithelium after widespread genetic ablation. (Hanovice NJ, Leach LL, Slater K, Gabriel AE, Romanovicz D, Shao E, Collery R, Burton EA, Lathrop KL, Link BA, Gross JM) PLoS Genet 2019 Jan;15(1):e1007939 39 Citations |
| 1 | Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17. (Yu JJ, Agrón E, Clemons TE, Domalpally A, van Asten F, Keenan TD, Cukras C, Chew EY, Age-Related Eye Disease Study 2 Research Group) Ophthalmology 2019 Feb;126(2):261-273 41 Citations |
| 1 | Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16. (Keenan TD, Agrón E, Domalpally A, Clemons TE, van Asten F, Wong WT, Danis RG, Sadda S, Rosenfeld PJ, Klein ML, Ratnapriya R, Swaroop A, Ferris FL 3rd, Chew EY, AREDS2 Research Group) Ophthalmology 2018 Dec;125(12):1913-1928 150 Citations |
| 1 | Mechanisms enhancing the protective functions of macular xanthophylls in the retina during oxidative stress. (Widomska J, Subczynski WK) Exp Eye Res 2019 Jan;178:238-246 18 Citations |
| 1 | Automatic Cone Photoreceptor Localisation in Healthy and Stargardt Afflicted Retinas Using Deep Learning. (Davidson B, Kalitzeos A, Carroll J, Dubra A, Ourselin S, Michaelides M, Bergeles C) Sci Rep 2018 May 21;8(1):7911 56 Citations |
| 1 | Exome-wide association study of plasma lipids in >300,000 individuals. (Liu DJ, Peloso GM, Yu H, Butterworth AS, Wang X, Mahajan A, Saleheen D, Emdin C, Alam D, Alves AC, Amouyel P, Di Angelantonio E, Arveiler D, Assimes TL, Auer PL, Baber U, Ballantyne CM, Bang LE, Benn M, Bis JC, Boehnke M, Boerwinkle E, Bork-Jensen J, Bottinger EP, Brandslund I, Brown M, Busonero F, Caulfield MJ, Chambers JC, Chasman DI, Chen YE, Chen YI, Chowdhury R, Christensen C, Chu AY, Connell JM, Cucca F, Cupples LA, Damrauer SM, Davies G, Deary IJ, Dedoussis G, Denny JC, Dominiczak A, Dubé MP, Ebeling T, Eiriksdottir G, Esko T, Farmaki AE, Feitosa MF, Ferrario M, Ferrieres J, Ford I, Fornage M, Franks PW, Frayling TM, Frikke-Schmidt R, Fritsche LG, Frossard P, Fuster V, Ganesh SK, Gao W, Garcia ME, Gieger C, Giulianini F, Goodarzi MO, Grallert H, Grarup N, Groop L, Grove ML, Gudnason V, Hansen T, Harris TB, Hayward C, Hirschhorn JN, Holmen OL, Huffman J, Huo Y, Hveem K, Jabeen S, Jackson AU, Jakobsdottir J, Jarvelin MR, Jensen GB, Jørgensen ME, Jukema JW, Justesen JM, Kamstrup PR, Kanoni S, Karpe F, Kee F, Khera AV, Klarin D, Koistinen HA, Kooner JS, Kooperberg C, Kuulasmaa K, Kuusisto J, Laakso M, Lakka T, Langenberg C, Langsted A, Launer LJ, Lauritzen T, Liewald DCM, Lin LA, Linneberg A, Loos RJF, Lu Y, Lu X, Mägi R, Malarstig A, Manichaikul A, Manning AK, Mäntyselkä P, Marouli E, Masca NGD, Maschio A, Meigs JB, Melander O, Metspalu A, Morris AP, Morrison AC, Mulas A, Müller-Nurasyid M, Munroe PB, Neville MJ, Nielsen JB, Nielsen SF, Nordestgaard BG, Ordovas JM, Mehran R, O'Donnell CJ, Orho-Melander M, Molony CM, Muntendam P, Padmanabhan S, Palmer CNA, Pasko D, Patel AP, Pedersen O, Perola M, Peters A, Pisinger C, Pistis G, Polasek O, Poulter N, Psaty BM, Rader DJ, Rasheed A, Rauramaa R, Reilly DF, Reiner AP, Renström F, Rich SS, Ridker PM, Rioux JD, Robertson NR, Roden DM, Rotter JI, Rudan I, Salomaa V, Samani NJ, Sanna S, Sattar N, Schmidt EM, Scott RA, Sever P, Sevilla RS, Shaffer CM, Sim X, Sivapalaratnam S, Small KS, Smith AV, Smith BH, Somayajula S, Southam L, Spector TD, Speliotes EK, Starr JM, Stirrups KE, Stitziel N, Strauch K, Stringham HM, Surendran P, Tada H, Tall AR, Tang H, Tardif JC, Taylor KD, Trompet S, Tsao PS, Tuomilehto J, Tybjaerg-Hansen A, van Zuydam NR, Varbo A, Varga TV, Virtamo J, Waldenberger M, Wang N, Wareham NJ, Warren HR, Weeke PE, Weinstock J, Wessel J, Wilson JG, Wilson PWF, Xu M, Yaghootkar H, Young R, Zeggini E, Zhang H, Zheng NS, Zhang W, Zhang Y, Zhou W, Zhou Y, Zoledziewska M, Charge Diabetes Working Group, EPIC-InterAct Consortium, EPIC-CVD Consortium, GOLD Consortium, VA Million Veteran Program, Howson JMM, Danesh J, McCarthy MI, Cowan CA, Abecasis G, Deloukas P, Musunuru K, Willer CJ, Kathiresan S) Nat Genet 2017 Dec;49(12):1758-1766 426 Citations |
| 2 | Reliability and Repeatability of Cone Density Measurements in Patients With Stargardt Disease and RPGR-Associated Retinopathy. (Tanna P, Kasilian M, Strauss R, Tee J, Kalitzeos A, Tarima S, Visotcky A, Dubra A, Carroll J, Michaelides M) Invest Ophthalmol Vis Sci 2017 Jul 01;58(9):3608-3615 40 Citations |
| 1 | Evaluating the Validity of the Age-Related Eye Disease Study Grading Scale for Age-Related Macular Degeneration: AREDS2 Report 10. (Vitale S, Clemons TE, Agrón E, Ferris FL 3rd, Domalpally A, Danis RP, Chew EY, Age-Related Eye Disease Study 2 (AREDS2) Research Group) JAMA Ophthalmol 2016 Sep 01;134(9):1041-7 23 Citations |
| 1 | The Association of Statin Use with Cataract Progression and Cataract Surgery: The AREDS2 Report Number 8. (AREDS2 Research Group, Al-Holou SN, Tucker WR, Agrón E, Clemons TE, Sperduto RD, Ferris FL 3rd, Chew EY) Ophthalmology 2016 Apr;123(4):916-7 14 Citations |
| 2 | Mining Retrospective Data for Virtual Prospective Drug Repurposing: L-DOPA and Age-related Macular Degeneration. (Brilliant MH, Vaziri K, Connor TB Jr, Schwartz SG, Carroll JJ, McCarty CA, Schrodi SJ, Hebbring SJ, Kishor KS, Flynn HW Jr, Moshfeghi AA, Moshfeghi DM, Fini ME, McKay BS) Am J Med 2016 Mar;129(3):292-8 70 Citations |
| 1 | Pathogenic variants for Mendelian and complex traits in exomes of 6,517 European and African Americans: implications for the return of incidental results. (Tabor HK, Auer PL, Jamal SM, Chong JX, Yu JH, Gordon AS, Graubert TA, O'Donnell CJ, Rich SS, Nickerson DA, NHLBI Exome Sequencing Project, Bamshad MJ) Am J Hum Genet 2014 Aug 07;95(2):183-93 69 Citations |
| 4 | Cone structure in subjects with known genetic relative risk for AMD. (Land ME, Cooper RF, Young J, Berg E, Kitchner T, Xiang Q, Szabo A, Ivacic LC, Stepien KE, Page CD, Carroll J, Connor T Jr, Brilliant M) Optom Vis Sci 2014 Aug;91(8):939-49 12 Citations |
| 1 | Paraproteinemic maculopathy. (Mansour AM, Arevalo JF, Badal J, Moorthy RS, Shah GK, Zegarra H, Pulido JS, Charbaji A, Amselem L, Lavaque AJ, Casella A, Ahmad B, Paschall JG, Caimi A, Staurenghi G) Ophthalmology 2014 Oct;121(10):1925-32 33 Citations |
| 1 | Rap1 GTPase activation and barrier enhancement in rpe inhibits choroidal neovascularization in vivo. (Wittchen ES, Nishimura E, McCloskey M, Wang H, Quilliam LA, Chrzanowska-Wodnicka M, Hartnett ME) PLoS One 2013;8(9):e73070 32 Citations |
| 1 | Evaluation of optimized digital fundus reflex photographs for lens opacities in the age-related eye disease study 2: AREDS2 report 7. (Domalpally A, Danis RP, Chew EY, Clemons TE, Reed S, Sangiovanni JP, Ferris FL 3rd, Age-Related Eye Disease Study 2 Research Group) Invest Ophthalmol Vis Sci 2013 Sep 05;54(9):5989-94 7 Citations |
| 1 | Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2). (Danis RP, Domalpally A, Chew EY, Clemons TE, Armstrong J, SanGiovanni JP, Ferris FL 3rd, AREDS2 Study Group) Invest Ophthalmol Vis Sci 2013 Jul 08;54(7):4548-54 99 Citations |
| 1 | Twelve-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration. (Busbee BG, Ho AC, Brown DM, Heier JS, Suñer IJ, Li Z, Rubio RG, Lai P, HARBOR Study Group) Ophthalmology 2013 May;120(5):1046-56 463 Citations |
| 1 | Structural aspects of the antioxidant activity of lutein in a model of photoreceptor membranes. (Wisniewska-Becker A, Nawrocki G, Duda M, Subczynski WK) Acta Biochim Pol 2012;59(1):119-24 8 Citations |
| 1 | A case for routine tonometry to avoid postoperative visual loss. (Usoltsev NA, Shankar H, Zainer CM) Br J Anaesth 2011 Oct;107(4):648-9 2 Citations |
| 1 | Pegaptanib sodium as maintenance therapy in neovascular age-related macular degeneration: the LEVEL study. (Friberg TR, Tolentino M, LEVEL Study Group, Weber P, Patel S, Campbell S, Goldbaum M) Br J Ophthalmol 2010 Dec;94(12):1611-7 45 Citations |
| 2 | Physician assessment of changing lesion size of predominantly classic choroidal neovascular membranes in age-related macular degeneration. (Covert DJ, Han DP, Kim JE, Connor TB Jr, Wirostko WJ, Moon SJ, Hamilton R) Ophthalmic Surg Lasers Imaging 2009;40(6):554-60 |
| 1 | S156C mutation in tissue inhibitor of metalloproteinases-3 induces increased angiogenesis. (Qi JH, Dai G, Luthert P, Chaurasia S, Hollyfield J, Weber BH, Stöhr H, Anand-Apte B) J Biol Chem 2009 Jul 24;284(30):19927-36 41 Citations |
| 1 | Improved vision-related function after ranibizumab vs photodynamic therapy: a randomized clinical trial. (Bressler NM, Chang TS, Fine JT, Dolan CM, Ward J, Anti-VEGF Antibody for the Treatment of Predominantly Classic Choroidal Neovascularization in Age-Related Macular Degeneration (ANCHOR) Research Group) Arch Ophthalmol 2009 Jan;127(1):13-21 86 Citations |
| 1 | Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study. (Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T, ANCHOR Study Group) Ophthalmology 2009 Jan;116(1):57-65.e5 1230 Citations |
| 1 | Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trial. (Chang TS, Bressler NM, Fine JT, Dolan CM, Ward J, Klesert TR, MARINA Study Group) Arch Ophthalmol 2007 Nov;125(11):1460-9 208 Citations |
| 1 | Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. (Kaiser PK, Blodi BA, Shapiro H, Acharya NR, MARINA Study Group) Ophthalmology 2007 Oct;114(10):1868-75 201 Citations |
| 1 | Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration. (Boyer DS, Antoszyk AN, Awh CC, Bhisitkul RB, Shapiro H, Acharya NR, MARINA Study Group) Ophthalmology 2007 Feb;114(2):246-52 379 Citations |
| 1 | Ranibizumab versus verteporfin for neovascular age-related macular degeneration. (Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S, ANCHOR Study Group) N Engl J Med 2006 Oct 05;355(14):1432-44 3266 Citations |
| 1 | Distribution of macular xanthophylls between domains in a model of photoreceptor outer segment membranes. (Wisniewska A, Subczynski WK) Free Radic Biol Med 2006 Oct 15;41(8):1257-65 38 Citations |
| 1 | Transpupillary thermotherapy with indocyanine green dye enhancement for the treatment of occult subfoveal choroidal neovascularization in age-related macular degeneration. (Kim JE, Shah KB, Han DP, Connor TB Jr) Ophthalmic Surg Lasers Imaging 2006;37(4):272-7 8 Citations |
| 1 | Pegaptanib for neovascular age-related macular degeneration. (Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR, VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group) N Engl J Med 2004 Dec 30;351(27):2805-16 2250 Citations |
| 1 | Transpupillary thermotherapy of occult choroidal neovascularization in age-related macular degeneration. (Kim JE, Perkins SL, Schwiesow T, Connor TB Jr, Han DP) Semin Ophthalmol 2001 Jun;16(2):86-9 17 Citations |
| 1 | Age-related macular degeneration is an inflammatory disease possibly treatable with minocycline. (Wirostko E, Wirostko WJ, Wirostko BM) Acta Ophthalmol Scand 2004 Apr;82(2):243-4 6 Citations |
| 1 | A 14-year old boy with presumed autosomal dominant macular dystrophy causing moderate visual impairment with no discernible progression over several years. (Ruttum M, Connor TB Jr, Traboulsi EI) J Pediatr Ophthalmol Strabismus 1999;36(5):287-91 |
| 1 | Bilateral macular vitelliform lesions in a thrombocytopenic patient. (Raja SC, Fekrat S, Connor TB Jr) Arch Ophthalmol 1995 Apr;113(4):411-3 4 Citations |
| 1 | Surgical removal of an extrafoveal fibrotic choroidal neovascular membrane with foveal serous detachment in age-related macular degeneration. (Connor TB Jr, Wolf MD, Arrindell EL, Mieler WF) Retina 1994;14(2):125-9 61 Citations |
